secwatch.observer — SEC 8-K summary
======================================

Issuer:     HeartSciences Inc. (HSCS)
CIK:        0001468492
Form:       8-K
Filed at:   2026-03-16T23:59:59+00:00
Accession:  0001437749-26-008420
Event type: earnings
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HeartSciences reports no FQ3 2026 revenue, cash at $3.4M; MyoVista platform advances
--------------------------------------------------------------------------------

- No revenue for FQ3 2026; cash and equivalents $3.4M, shareholders' equity $2.7M as of Jan 31.
- MyoVista Insights platform got major upgrade March 13; deploying across health systems.
- MyoVista wavECG device submitted to FDA for 510(k) clearance in Dec 2025.
- Company expects key customer wins and initial revenues during 2026.
- Management to host investor call after ACC meeting to demo platform.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1468492/000143774926008420/0001437749-26-008420-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1468492/000143774926008420/hscs20251229_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-008420

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer